ATH 0.00% 0.4¢ alterity therapeutics limited

Ann: Appendix 3B , page-4

  1. 221 Posts.
    lightbulb Created with Sketch. 90
    I think the message prior to trial results was that Prana should raise whatever level of cash they think prudent to cover the possibility of disappointing results. They should raise that cash in one share issue (like the SPP about 18 months ago) and then stop interfering with the normal market mechanism. The continual drip feed of issues was dampening potential upside. They only needed to raise cash prior to the event for the possibilty of bad results since they could've raised whatever they liked at much higher prices after good results.

    The problem wasn't raising funds per se, it was the manner in which they were doing it.

    The latest issue indicates either they didn't anticpate disappointing results or the $25m they have on hand wasn't prudent enough or some other path forward is being taken which wasn't in their earlier planning.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $18.62M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $886 275.3K

Buyers (Bids)

No. Vol. Price($)
48 56368671 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 125986200 26
View Market Depth
Last trade - 11.34am 30/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.